Who We Are
Our mission is to lengthen your healthspan, the amount of time you live in good health.
Scientific Advisory Board
Top scientists and industry leaders that lead us forward
Charles Brenner, Ph.D.,
HEAD OF BIOCHEMISTRY
UNIVERSITY OF IOWA
World's foremost authority on NAD+ Metabolism
Roger Kornberg, Ph.D
PROFESSOR OF STRUCTURAL BIOLOGY
Nobel Prize Winner, Chemistry, 2006
Rudolph Tanzi, Ph.D.
KENNEDY PROFESSOR OF NEUROLOGY
Leading Alzheimer's Researcher, Time100 Most Influential 2015
Dr. Bruce German
CHAIRMAN OF FOOD, NUTRITION, & HEALTH
UNIVERSITY OF CALIFORNIA, DAVIS
Leader in Food, Nutrition & wellness innovation
Dr. Matthew Roberts
Innovation Executive, Abbott, Nestle, NBTY
Senior Scientific Advisor, Nestle Research Center
ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary health and wellness consumer products and nutritional ingredient technologies that promote healthy longevity. It’s latest acquisition includes a novel nicotinamide riboside nutritional supplement, TRU NIAGEN™. In addition to our consumer product and ingredient technologies units, we also have business units focused on natural product fine chemicals (known as "phytochemicals"), and product regulatory and safety consulting. As a result of our relationships with leading universities and research institutions, we are able to discover and license early stage, IP-backed ingredient technologies. We then utilize our in-house chemistry, regulatory and safety consulting business units to develop commercially viable ingredients. Our consumer product and ingredient portfolio are backed with clinical and scientific research, as well as extensive IP protection. Our portfolio of patented ingredient technologies includes NIAGEN® nicotinamide riboside; pTeroPure® pterostilbene; PURENERGY®, a caffeine-pTeroPure®co-crystal; IMMULINA™, a spirulina extract; and AnthOrigin™, anthocyanins derived from a domestically-produced, water-extracted purple corn husk.
ChromaDex, Inc. is listed on NASDAQ, stock name CDXC.
Chief Executive Officer
President and Chief Strategy Officer
Chief Operating Officer
Amy Boileau, PhD, RD
Chief Financial Officer